DESANTIS, VANESSA
 Distribuzione geografica
Continente #
NA - Nord America 2.260
AS - Asia 1.317
EU - Europa 851
SA - Sud America 405
AF - Africa 74
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.913
Nazione #
US - Stati Uniti d'America 2.188
SG - Singapore 605
BR - Brasile 360
CN - Cina 277
IT - Italia 194
HK - Hong Kong 180
RU - Federazione Russa 165
SE - Svezia 126
DE - Germania 115
VN - Vietnam 88
GB - Regno Unito 62
FR - Francia 49
CA - Canada 40
CI - Costa d'Avorio 31
IN - India 30
ID - Indonesia 29
FI - Finlandia 28
NL - Olanda 22
MX - Messico 20
ZA - Sudafrica 20
AR - Argentina 18
ES - Italia 18
PL - Polonia 17
TR - Turchia 13
AT - Austria 12
BD - Bangladesh 12
IQ - Iraq 12
JP - Giappone 12
LT - Lituania 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
BE - Belgio 6
EC - Ecuador 6
JO - Giordania 6
AU - Australia 5
CH - Svizzera 5
CL - Cile 5
MA - Marocco 5
SA - Arabia Saudita 5
UA - Ucraina 5
UZ - Uzbekistan 5
EG - Egitto 4
KE - Kenya 4
KR - Corea 4
PH - Filippine 4
PK - Pakistan 4
CO - Colombia 3
DK - Danimarca 3
IR - Iran 3
OM - Oman 3
PY - Paraguay 3
BH - Bahrain 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HN - Honduras 2
IE - Irlanda 2
IL - Israele 2
MO - Macao, regione amministrativa speciale della Cina 2
NP - Nepal 2
RS - Serbia 2
SN - Senegal 2
TW - Taiwan 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BS - Bahamas 1
CD - Congo 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
EE - Estonia 1
GD - Grenada 1
GM - Gambi 1
GT - Guatemala 1
HT - Haiti 1
IS - Islanda 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LU - Lussemburgo 1
LV - Lettonia 1
MG - Madagascar 1
MY - Malesia 1
NO - Norvegia 1
PE - Perù 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 4.913
Città #
Ashburn 379
Singapore 310
Chandler 208
Hong Kong 176
Fairfield 172
Woodbridge 130
Nyköping 114
Beijing 113
New York 87
Seattle 83
Cambridge 81
Los Angeles 74
Houston 70
Bari 68
Wilmington 65
Ann Arbor 60
Dallas 51
Munich 47
São Paulo 38
Abidjan 31
Ho Chi Minh City 27
Jakarta 27
Lawrence 26
Roxbury 26
Brooklyn 24
Chicago 20
Dearborn 19
Falkenstein 19
Frankfurt am Main 19
Nanjing 19
Rome 19
Inglewood 18
Des Moines 17
Dong Ket 17
Johannesburg 17
Buffalo 15
Chennai 15
Helsinki 15
Toronto 15
London 14
Moscow 14
Curitiba 13
Denver 13
Hanoi 13
Montreal 13
Orem 13
Phoenix 13
Rio de Janeiro 13
Santa Clara 13
Tokyo 12
Marseille 11
San Diego 11
Warsaw 11
Boston 10
Grafing 10
Poplar 10
Campinas 9
Washington 9
Manchester 8
Nuremberg 8
Princeton 8
Guangzhou 7
Hebei 7
Mexico City 7
Turku 7
Amman 6
Ankara 6
Brussels 6
Goiânia 6
Guarulhos 6
Paris 6
Porto Alegre 6
The Dalles 6
Amsterdam 5
Atlanta 5
Baghdad 5
Belo Horizonte 5
Brasília 5
Buenos Aires 5
Jacksonville 5
Jinan 5
Manaus 5
Pune 5
Roubaix 5
Augusta 4
Boardman 4
Brescia 4
Canoas 4
Changsha 4
Columbus 4
Council Bluffs 4
Da Nang 4
Dhaka 4
Düsseldorf 4
Florence 4
Lahore 4
Nairobi 4
Ningbo 4
Ottawa 4
Rotherham 4
Totale 3.175
Nome #
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 194
Isolation and characterization of neural stem cells from dystrophic mdx mouse 189
Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro 170
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 163
Microenvironment drug resistance in multiple myeloma: Emerging new players 157
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 153
Halting prosurvival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes Bortezomid resistance in multiple myeloma patients. 149
Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus 138
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma 138
Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients 135
“miRNAs profile of bone marrow fibroblasts in multiple myeloma: relationship with disease progression and drug-resistance” 135
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 124
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma 121
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 118
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma 111
“Exosomes-Mediate Crosstalk in Multiple Myeloma progression and drug Resistance” 110
Erratum: Corrigendum to “Isolation and characterization of neural stem cells from dystrophic mdx mouse” (Experimental Cell Research (2016) 343(1) (190–207) (S0014482716300593) (10.1016/j.yexcr.2016.03.019)) 108
Diabetes and alzheimer’s disease: Might mitochondrial dysfunction help deciphering the common path? 95
The role of SIRT6 in tumors 89
ROLE OF CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND CORRELATION WITH VASCULAR STIFFNESS AND ORGAN DAMAGE 85
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma 85
FGF trapping inhibits multiple myeloma growth through c-Myc degradation–induced mitochondrial oxidative stress 84
Two-year follow-up after drug desensitization in mucopolysaccharidosis 82
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease 82
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 81
Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion 81
Clinical response and analysis of regulatory T cells (Tregs) in a cohort of patients with active Systemic Lupus Erythematosus (SLE) on treatment with belimumab. 80
A Challenging Case of Visceral Leishmaniasis 79
Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs 79
Antiangiogenic drugs as chemosensitizers in hematological tumors 76
Breaking through Multiple Myeloma: A Paradigm for a Comprehensive Tumor Ecosystem Targeting 72
A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study 69
Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance 69
Comprehensive analysis of clinical outcomes, infectious complications and microbiological data in newly diagnosed multiple myeloma patients: a retrospective observational study of 92 subjects 66
CORRELATION BETWEEN VASCULAR INFLAMMATION MARKERS, DIASTOLIC DYSFUNCTION AND CARDIOVASCULAR RISK IN PATIENTS WITH TAKAYASU ARTERITIS 66
Genomic profiling at a single center cracks the code in inborn errors of immunity 64
Targeting the immune microenvironment in Waldenström Macroglobulinemia via halting the CD40/CD40-ligand axis 63
Epigenetic regulation of angiogenesis in tumor progression 62
STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failure 61
Changes in Lipids in Granulomatosis with Polyangiitis Relates to Glucocorticoids and History of Hypertension 58
The Landscape of lncRNAs in Multiple Myeloma: Implications in the “Hallmarks of Cancer”, Clinical Perspectives and Therapeutic Opportunities 58
LIPIDS INCREASE IN HYPERTENSIVES DURING THE FIRST YEAR STEROID TREATMENT FOR GRANULOMATOSIS WITH POLYANGIITIS (GPA) 56
Immune disturbance leads to pulmonary embolism in COVID-19 more than classical risk factors: a clinical and histological study 54
IMPACT OF REMOTE MONITORING ON PATIENTS’ QUALITY OF LIFE. A SINGLE CENTRE STUDY 53
The Complexity of the Tumor Microenvironment in Hepatocellular Carcinoma and Emerging Therapeutic Developments 52
Thrombopoietin promotes angiogenesis and disease progression in patients with multiple myeloma 50
Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications 50
MicroRNAs-based nano-strategies as new therapeutic approach in multiple myeloma to overcome disease progression and drug resistance 50
Non-Anticoagulation Strategies Aimed at Primary Stroke Prevention in Nascent Atrial Fibrillation. 48
microRNAs as Biomarkers of Endothelial Dysfunction and Therapeutic Target in the Pathogenesis of Atrial Fibrillation 48
Correlation between atrial cardiomyopathy and predictive biomarkers of cryptogenic stroke in primary and secondary prophylaxis: potential role of endothelial progenitor cell (EPCs) dysfunction 47
Navigating Lymphomas through BCR Signaling and Double-Hit Insights: Overview 45
GENDER DISPARITIES IN HYPERTENSIVE PATIENTS ACROSS THE LIFETIME: AN AGE-STRATIFIED ANALYSIS 41
null 39
The Leading Role of the Immune Microenvironment in Multiple Myeloma: A New Target with a Great Prognostic and Clinical Value 38
Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro 37
High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis 36
Role of extracellular vesicle-based cell-to-cell communication in multiple myeloma progression 36
Efficacy and Safety of Mepolizumab 300 mg in Eosinophilic Granulomatosis With Polyangiitis: A Meta-Analysis of Eight Retrospective Studies 34
How to manage hypersensitivity reactions to enzyme replacement therapy in lysosomal storage diseases? 34
Mast Cells and Interleukins 31
Visualizing the Interactions Shaping the Imaging of the Microenvironment in Human Cancers 31
Spatial imaging unlocks the potential of charting multiple myeloma and extramedullary disease 26
Successful rapid desensitization to zoledronic acid in a multiple myeloma patient 26
Ocular Side Effects of Dupilumab: A Comprehensive Overview of the Literature 21
Tunneling nanotubes between bone marrow stromal cells support transmitophagy and resistance to apoptosis in myeloma 18
Aberrant single-cell phenotype and clinical implications of genotypically defined polyclonal plasma cells in myeloma 18
Progressive NK Cell Dysfunction and ILC Imbalance Favor Immune Evasion in Multiple Myeloma 11
Case Report: Disseminated leishmaniasis and rheumatoid arthritis: navigating a clinical conundrum 9
Addressing Endothelial Dysfunction in Heart Failure: The Role of Endothelial Progenitor Cells and New Treatment Horizons 6
Totale 5.244
Categoria #
all - tutte 23.649
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.649


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021258 0 0 0 0 0 29 47 33 30 56 29 34
2021/2022252 11 18 4 10 8 17 14 11 19 26 38 76
2022/2023454 43 78 38 46 35 63 9 56 65 10 9 2
2023/2024277 19 27 17 23 31 105 7 8 0 17 6 17
2024/20251.457 50 24 43 48 52 131 280 153 78 92 177 329
2025/20261.737 457 165 226 380 466 43 0 0 0 0 0 0
Totale 5.244